Showing results (31-40 of 320) with videos related to
Sort By:
Pageof 32
Cardiovascular Research|December 31, 2002
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxationKonrad F Frank, Birgit Bölck, Erland Erdmann, et al.Vascular Health and Risk Management|November 1, 2007
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive studyErland Erdmann, John Dormandy, Robert Wilcox, et al.Clinical Cardiology|April 22, 2009
Magnetic resonance imaging of carcinoid heart diseaseDamian Franzen, Andree Boldt, Ute Raute-Kreinsen, et al.Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Treatment of stable coronary artery disease in type II diabetes mellitus: drugs, coronary intervention and bypass surgery]Christian A Schneider, Roman PfisterHerz|August 26, 2022
Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?Christian A Schneider, Roman PfisterNature Reviews. Cardiology|June 26, 2010
Diabetes: glycated hemoglobin is a marker of diabetes and CVD riskNicholas J Wareham, Roman PfisterFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox"Stephan Rosenkranz, Denis Knirel, Helmut Dietrich, et al.ALTEX|January 1, 1993
[Studies about the effects of positive inotropic and vasoactive substances]Robert H. G. Schwinger, Michael Böhm, Christian Schulz, et al.Diabetes & Vascular Disease Research|April 13, 2010
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA studyThomas Schöndorf, Georg Lübben, Efstrathios Karagiannis, et al.Journal of Thoracic Disease|February 1, 2019
Molecular mechanisms underlying cardiotoxicity of novel cancer therapeuticsSimon Braumann, Stephan Baldus, Roman PfisterPageof 32